Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD‐1 Inhibition as Potential Treatment Option

Author:

Mellinghoff Sibylle C.123ORCID,Thelen Martin45ORCID,von Bergwelt‐Baildon Michael678,Schlößer Hans A.45,Cornely Oliver A.1239ORCID,Sprute Rosanne123,Stemler Jannik123ORCID,Mayer Leonie101112,Weskamm Leonie Marie101112,Friedrich Monika101112,Ly My Linh101112,Dahlke Christine10,Addo Marylyn M.101112

Affiliation:

1. Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany

2. German Centre for Infection Research (DZIF), Partner Site Bonn‐Cologne Cologne Germany

3. Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging‐Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany

4. Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany

5. Department of General, Visceral, Thoracic, and Transplantation Surgery, Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany

6. Department III of Internal Medicine Ludwig Maximilian University of Munich Munich Germany

7. German Cancer Consortium (DKTK) Munich Germany

8. Comprehensive Cancer Center München‐LMU (CCCMLMU) LMU Munich Munich Germany

9. Clinical Trials Centre Cologne (ZKS Köln), Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany

10. Department of Clinical Immunology of Infectious Diseases Bernhard Nocht Institute for Tropical Medicine Hamburg Germany

11. Institute for Infection Research and Vaccine Development (IIRVD) University Medical Centre Hamburg‐Eppendorf Hamburg Germany

12. German Centre for Infection Research (DZIF), Partner Site Hamburg‐Lübeck‐Borstel‐Riems Hamburg Germany

Abstract

ABSTRACTBackgroundInvasive mould infections (IMI) cause substantial morbidity and mortality in populations at risk. Novel treatment approaches are urgently needed. Targeting immune checkpoints may reverse hyporesponsiveness of the innate and adaptive immune systems.MethodsIn this prospective, observational study, we investigated immune checkpoint expression levels on immune cells in patients with invasive aspergillosis (IA; n = 25) and mucormycosis (MU; n = 7). Healthy controls (HC; n = 5) and patients with matched haematological diseases but without IMI served as control populations (CP; n = 10). Multicolour flow cytometry analysis was used to compare immune cell subsets and the expression of immune‐regulatory molecules in peripheral blood mononuclear cells (PBMCs).ResultsLymphocyte subsets and immune phenotypes in PBMCs were similar between patients with IMI and haematological CP, except for regulatory T cells, which were increased in PBMCs of patients with IA and MU compared to HCs. In IA and MU, PBMCs showed increased expression of immune checkpoint molecules compared to healthy controls and matched haematological CP, with this effect being more pronounced in IA than in MU. We found heterogeneous, disease‐, molecule‐, and patient‐specific expression patterns of immune checkpoint molecules. For example, PD‐1 expression was highest in MU PBMCs, followed by IA PBMCs, while HC PBMCs showed lower expression levels. Overall mortality in our patient population was 44.0% (IPA) and 80.0% (MU).ConclusionsWe report an immune phenotype consistent with T‐cell exhaustion in IMI, indicating potential contributions from haematological treatment, underlying disease, and infection. However, the primary underlying cause remains unclear and requires further investigation. A marker that was notably higher in IMI patients was PD‐1, and treatment approaches specifically targeting this molecule may be promising.

Funder

Deutsches Zentrum für Infektionsforschung

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3